Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial.

DOI:10.1016/S1470-2045(26)00090-2
作者：Ziming Li,?Jie Hu,?Jianhua Chen,?Yan Yu,?Xiangjiao Meng,?Xiaorong Dong,?Yanping Hu,?Yinghua Ji,?Haifeng Liu,?Weibo Wang,?Fangling Ning,?Zhihong Zhang,?Chunling Liu,?Zhiye Zhang,?Qiming Wang,?Wei Zheng
文献类型：期刊论文
补充材料：只需要正文